NSE: APOLLOHOSP · 6 October 2026
- Apollo Hospitals Enterprise Limited (APOLLOHOSP) declined by 0.88% on Tuesday, closing at ₹7,914.50 after trading between an intraday high of ₹7,990.00 and a low of ₹7,807.50.
- Apollo Hospitals submitted the scrutinizer's report and voting results following a court-convened general meeting held on June 24, 2026, where shareholders voted on the composite scheme of arrangement involving its digital health platform and pharmacy distribution business.
- Trading volume was 2.33 times the 20-day average daily volume.
Why is Apollo Hospitals Enter. L share price falling on 6 October 2026?
Apollo Hospitals Enterprise Limited (APOLLOHOSP) declined by 0.88% on Tuesday, closing at ₹7,914.50 after trading between an intraday high of ₹7,990.00 and a low of ₹7,807.50.
The stock's negative movement contrasted with broader market indices on Tuesday. The benchmark Nifty rose 0.98%, and the Nifty Pharma sector index advanced 1.66%, indicating that Apollo Hospitals underperformed both the wider market and its sector peers.
While no new operational developments occurred on Tuesday, recent filings show the company is actively advancing its corporate reorganization, including a court-convened general meeting held on June 24, 2026, and subsequent shareholder votes regarding a composite scheme of arrangement for its digital health and pharmacy distribution businesses. These ongoing structural shifts provide corporate context but are not directly linked to today's intraday price pullback.
10.51 lakh shares traded by 6 October 2026 · 03:15 PM IST. This compares with a 20-day average daily volume of 4.52 lakh shares (2.33 times). The five-day average daily volume was 9.10 lakh shares. Separately, the NSE report for 5 October 2026 showed 5.22 lakh shares delivered, representing 58.37% of that day’s traded volume. The same report recorded 87,976 trades.
Apollo Hospitals shares drifted lower by 0.88% despite positive momentum in the broader Nifty Pharma sector, accompanied by elevated trading volume exceeding twice its 20-day average. In the absence of a same-day catalyst, the price action reflects typical market positioning and stock-specific selling pressure following recent multi-session weakness.
Latest Company Developments
Apollo Hospitals submitted the scrutinizer's report and voting results following a court-convened general meeting held on June 24, 2026, where shareholders voted on the composite scheme of arrangement involving its digital health platform and pharmacy distribution business.
It marks a key procedural step in the company's broader corporate restructuring and demerger plans.
The company reported its financial results for the quarter ended June 30, 2026, posting standalone revenue from operations of ₹26,561 million and a profit after tax of ₹3,852 million. Management also outlined ongoing expansion metrics across its healthcare services and digital pharmacy segments.
Provides baseline quarterly financial performance and operational visibility across core hospital and digital business units.
The company issued newspaper advertisements regarding the proposed transfer of equity shares with unclaimed dividends for seven consecutive financial years to the Investor Education and Protection Fund (IEPF) authority pursuant to statutory guidelines.
A standard regulatory compliance procedure concerning unclaimed shareholder dividends and associated equity shares.
a press release dated August 12, 2026, titled "Apollo Hospitals Q1FY27 Results".
Proceedings of Court Convened General Meeting held on Jun 24, 2026 along with a copy of minutes.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 17.33% on 30 June 2026. This compares with 16.65% on 31 March 2026, a change of +0.68 percentage points.
The filing reported 381 MF/UTI holders.
What to Watch Next
- Progress on the NCLT petition and implementation of the composite scheme of arrangement
- Delivery percentage and cash volume trends relative to the 20-day average volume of 2.33x
- Performance and operational scaling of the Apollo 24/7 digital health and pharmacy distribution units
- Quarterly financial trajectory and bed occupancy rates in the healthcare services segment
Other Dated Coverage
- Why Apollo Hospitals Shares Are Falling 2.44% Today | 1 October 2026 — 1 October 2026
- Why Apollo Hospitals Shares Dropped 6.64% Today: Heavy Volume Selloff | 30 September 2026 — 30 September 2026
- Why Apollo Hospitals Share Price Fell 2.27% Today | 29 September 2026 — 29 September 2026
More Apollo Hospitals Enter. L news and dated analysis →
Frequently Asked Questions
What is the latest Apollo Hospitals Enter. L company news?
Apollo Hospitals submitted the scrutinizer's report and voting results following a court-convened general meeting held on June 24, 2026, where shareholders voted on the composite scheme of arrangement involving its digital health platform and pharmacy distribution business.
How strong was Apollo Hospitals Enter. L’s trading volume?
10.51 lakh shares traded, 2.33 times the 20-day average daily volume. The price and volume data are dated 6 October 2026 · 03:15 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 June 2026. Quarterly holdings do not identify purchases made on the article date.
Article by: WittyTrades Research Desk
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.